Our response against pain and inflammation.

MIAT has developed and registered (Hybrid legal basis) in some European countries a medicated plaster based on Diclofenc Epolamine for the symptomatic local treatment of pain and inflammation of rheumatic or traumatic nature of joints, muscles, tendons and ligaments.

The product is available only through in-licensing.